The swinging thyroid in hepatitis C infection and interferon therapy.
Tran
H A
HA
Hunter Area Pathology Service and Newcastle University, Locked Bag No. 1, Hunter Mail Region Centre, Newcastle, New South Wales 2310, Australia. huy.tran@hnehealth.nsw.gov.au
D000998:Antiviral Agents / Q000009:adverse effects*; D001323:Autoantibodies / Q000097:blood / Q000378:metabolism; D004359:Drug Therapy, Combination / Q000009:adverse effects; D006526:Hepatitis C / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000627:therapeutic use; D011994:Recombinant Proteins; D013960:Thyroid Function Tests; D013966:Thyroiditis / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy; D013971:Thyrotoxicosis / Q000139:chemically induced*; D016896:Treatment Outcome
D000998:Antiviral Agents; D001323:Autoantibodies; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011433:Propranolol